Results 141 to 150 of about 998,540 (257)

Revistes d'accés obert : característiques, models econòmics i tendències

open access: yesBiD: Textos Universitaris de Biblioteconomia i Documentació, 2008
Existeixen exemples de revistes electròniques científiques d'accés obert (OA) des de l'aparició d'Internet. Tanmateix, amb la Declaració de Budapest, en la qual es defineix el significat d'accés obert i les revistes com una via per assolir-lo, comencen a
Melero, Remedios   +1 more
doaj  

In Memoriam: W. King Engel, MD (1930–2025)

open access: yes
Annals of Neurology, EarlyView.
Marinos C. Dalakas, Steven P. Ringel
wiley   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar   +35 more
wiley   +1 more source

Revistas open access : características, modelos económicos y tendencias

open access: yesBiD: Textos Universitaris de Biblioteconomia i Documentació, 2008
Existen ejemplos de revistas electrónica científicas de acceso abierto (open access, OA) desde la aparición de Internet, sin embargo con la Declaración de Budapest en la que se define el significado de OA y las revistas como una vía para alcanzarlo es ...
Melero, Remedios   +1 more
doaj  

A credit-like rating system to determine the legitimacy of scientific journals and publishers. [PDF]

open access: yesScientometrics, 2021
Teixeira da Silva JA   +3 more
europepmc   +1 more source

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

open access: yesArthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen   +14 more
wiley   +1 more source

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Juvenile idiopathic arthritis (JIA) is associated with impaired overall health‐related quality of life (HRQoL). We evaluated the impact of tofacitinib on patient‐reported outcomes (PROs) in patients with JIA. Methods This was a post hoc analysis of a phase 3, randomized, double‐blind, placebo‐controlled withdrawal trial (NCT02592434) in ...
Hermine I. Brunner   +21 more
wiley   +1 more source

Publishing Identifiable Patient Photographs in Scientific Journals: Scoping Review of Policies and Practices.

open access: yesJ Med Internet Res, 2022
Roguljić M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy